PRASUGREL

作品数:18被引量:32H指数:3
导出分析报告
相关领域:医药卫生更多>>
相关作者:杨文龙孙铁民李姗蓉更多>>
相关机构:上海交通大学医学院附属第九人民医院上海交通大学沈阳药科大学更多>>
相关期刊:《国外药讯》《中国药物化学杂志》《临床合理用药》《South China Journal of Cardiology》更多>>
-

检索结果分析

结果分析中...
条 记 录,以下是1-10
视图:
排序:
Trends in dual antiplatelet therapy regimens and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention with drug-eluting stents: A multicenter real-world study
《Chronic Diseases and Translational Medicine》2025年第1期57-68,共12页Preyanate Wilairat Arintaya Phrommintikul Thanyalak Chotayaporn Supharat Wattanasombat Rungtiwa Hmuenpha Supitchaya Kornjirakasemsan Duangkamon Poolpun Voratima Yoodee 
The Ajarn Kasem Pangsriwong Foundation supported the research project;Pharmaceutical Care Training Center(PCTC)at the Faculty of Pharmacy,Chiang Mai University。
Background:The patterns of dual antiplatelet therapy(DAPT)use and the associated clinical outcomes in current practice remain limited.This study evaluates DAPT regimen patterns and clinical outcomes among acute corona...
关键词:acute coronary syndrome CLOPIDOGREL dual antiplatelet therapy percutaneous coronary intervention PRASUGREL prescription pattern ticagrelor 
Dramatic recovery from stroke following intravenous thrombolysis in a patient on prasugrel for recent percutaneous coronary angioplasty
《Neuroimmunology and Neuroinflammation》2017年第10期216-218,共3页Salvadeeswaran Meenakshi-Sundaram Palanikumar Subburamakrishnan Jude Vinoth Simon Victor Rajah Sanjeevi Madhan-Rajah Somalinga Nagendran Karthik Pandi Suresh 
The authors report the first case of thrombolysis in a patient already receiving both aspirin and prasugrel following a recent ischemic coronary event. A 55-year-old gentleman was treated for inferior wall myocardial ...
关键词:INTRAVENOUS THROMBOLYSIS ischemic STROKE percutaneous coronary ANGIOPLASTY PRASUGREL 
P2Y12-ADP receptor antagonists: Days of future and past被引量:4
《World Journal of Cardiology》2016年第5期327-332,共6页Marc Laine Franck Paganelli Laurent Bonello 
Antiplatelet therapy is the cornerstone of the therapeutic arsenal in coronary artery disease.Thanks to a better understanding in physiology,pharmacology and pharmacogenomics huge progress were made in the field of pl...
关键词:CLOPIDOGREL PRASUGREL Ticagrelor Acute coronary syndrome Ticagrelor CANGRELOR 
Current status of high on-treatment platelet reactivity in patients with coronary or peripheral arterial disease:Mechanisms,evaluation and clinical implications被引量:17
《World Journal of Cardiology》2015年第12期912-921,共10页Stavros Spiliopoulos Georgios Pastromas 
Antiplatelet therapy with aspirin or clopidogrel or both is the standard care for patients with proven coronary or peripheral arterial disease,especially those undergoing endovascular revascularization procedures. How...
关键词:CORONARY DISEASE Clopidogrel Aspirin HIGH on TREATMENT platelet reactivity Peripheral arterial DISEASE ANTIPLATELET therapy Ticagrelor PRASUGREL 
Time-effect and dose-effect of prasugrel hydrobromide acetic acid compound inhibiting platelet aggregation
《中国药理学通报》2015年第B11期178-178,共1页
Aim To evaluate the time-effect and dose-effect of prasugrel hydrobromide acetic acid compound (PHAAC) inhibiting platelet aggregation. Methods For the time-effect study, 190 Sprague-Dawley (SD) rats were devided ...
关键词:PRASUGREL hydrobromide acetic acid compound platelet aggregation time-effect DOSE-EFFECT prasug-rel HYDROCHLORIDE 
Pharmacokinetics and pharmacodynamics of single and multiple doses of prasugrel in healthy native Chinese subjects被引量:2
《Acta Pharmacologica Sinica》2012年第11期1395-1400,共6页Yi-min CUI Zi-ning WANG Xiao-wen CHEN Hui-lin ZHANG Xia ZHAO Ying ZHOU 
Aim: To characterize the pharmacokinetics (PKs), pharmacodynamics (PDs), and tolerability of different dose regimens of prasugrel in healthy Chinese subjects. Methods: This was a single-centered, open-label, par...
关键词:PRASUGREL platelet aggregation PHARMACOKINETICS PHARMACODYNAMICS dose regimen healthy Chinese subject 
Standardizing a simpler, more sensitive and accurate tail bleeding assay in mice被引量:6
《World Journal of Experimental Medicine》2012年第2期30-36,共7页Yang Liu Nicole L Jennings Anthony M Dart Xiao-Jun Du 
Supported by Project and Fellowship Grants from the National Health and Medical Research Council of Australia
AIM: To optimize the experimental protocols for a simple, sensitive and accurate bleeding assay.METHODS: Bleeding assay was performed in mice by tail tip amputation, immersing the tail in saline at 37 ℃, continuously...
关键词:Mouse or MICE TAIL BLEEDING ASSAY PRASUGREL Platelets Hemostasis FcRγ 
Esophageal mucosal lesion with low-dose aspirin and prasugrel mimics malignancy: A case report被引量:1
《World Journal of Gastroenterology》2011年第35期4048-4051,共4页Gui-Fen Ma Hong Gao Shi-Yao Chen 
Dual antiplatelet therapy consisting of low-dose aspirin (LDA) and other antiplatelet medications is recommended in patients with coronary heart disease, but it may increase the risk of esophageal lesion and bleeding....
关键词:Esophageal injury Low-dose aspirin PRASUGREL Gastrointestinal hemorrhage Drug-eluting stent 
Prasugrel versus clopidogrel in acute coronary syndrome patients undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials被引量:1
《South China Journal of Cardiology》2010年第4期238-245,249,共9页张步春 车文良 刘伟静 徐亚伟 
Background Clopidogrel is beneficial after acute coronary syndrome. Recent studies suggest the superiority of prasugrel compared with clopidogrel. The enhanced platelet inhibition with prasugrel lead to a reduction in...
关键词:acute coronary syndrome META-ANALYSIS PRASUGREL CLOPIDOGREL 
Alternatives to clopidogrel for acute coronary syndromes:Prasugrel or ticagrelor?被引量:1
《World Journal of Cardiology》2010年第6期131-134,共4页Giuseppe Biondi-Zoccai Marzia Lotrionte Fiorenzo Gaita 
Clopidogrel is a mainstay in the treatment of patients with acute coronary syndromes or those receiving endovascular prostheses.However,its efficacy has been challenged in the recent past by studies suggesting variabl...
关键词:ACUTE CORONARY SYNDROME CLOPIDOGREL PRASUGREL Ticagrelor 
检索报告 对象比较 聚类工具 使用帮助 返回顶部